Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Leventhal

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Abdominal Radiology (New York)|January 31, 2023
Melanoma in pregnancyFerenc Czeyda-Pommersheim, Harriet Kluger, Jonathan Langdon, et al.
The Oncologist|October 6, 2020
Dermatologic Adverse Events Associated with Selective Fibroblast Growth Factor Receptor Inhibitors: Overview, Prevention, and Management GuidelinesMario E Lacouture, Vincent Sibaud, Milan J Anadkat, et al.
Journal of Drugs in Dermatology : JDD|December 4, 2024
INDIVIDUAL ARTICLE: USCOM IV Algorithm for the Prevention and Management of Targeted Therapy-Related Cutaneous Adverse EventsJonathan Leventhal, Ana Sofia Acosta Madiedo, Anneke Andriessen, et al.
Journal of Drugs in Dermatology : JDD|September 7, 2021
US Cutaneous Oncodermatology Management (USCOM): A Practical AlgorithmMario E Lacouture, Jennifer Choi, Alice Ho, et al.
Journal of Addiction Medicine|November 7, 2023
Recognition and Treatment of Wounds in Persons Using Xylazine: A Case Report From New Haven, ConnecticutAnne Dowton, Molly Doernberg, Erica Heiman, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|July 9, 2025
New Drugs, New Toxicities: Side Effects of New and Emerging Breast Cancer TherapiesAlexis LeVee, Alana Deutsh, Ethan S Lindgren, et al.
Frontiers in Oncology|November 14, 2025
Use of imiquimod topical therapy for management of malignant melanoma positive marginsKatelyn Lewis, Sara Islam, David P Alper, et al.
Frontiers in Oncology|February 23, 2023
Factors associated with the use of adjuvant radiation therapy in stage III melanomaAmber L O King, Victor Lee, Beverly Yu, et al.
Journal for Immunotherapy of Cancer|June 16, 2019
B cell depletion or absence does not impede anti-tumor activity of PD-1 inhibitorsWilliam Damsky, Lucia Jilaveanu, Noel Turner, et al.
JAAD Case Reports|July 3, 2020
Neoadjuvant anti-programmed cell death 1 therapy for locally advanced basal cell carcinoma in treatment-naive patients: A case seriesKatherine Given Ligtenberg, Jamie Katy Hu, William Damsky, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Abdominal Radiology (New York)|January 31, 2023
Melanoma in pregnancyFerenc Czeyda-Pommersheim, Harriet Kluger, Jonathan Langdon, et al.
The Oncologist|October 6, 2020
Dermatologic Adverse Events Associated with Selective Fibroblast Growth Factor Receptor Inhibitors: Overview, Prevention, and Management GuidelinesMario E Lacouture, Vincent Sibaud, Milan J Anadkat, et al.
Journal of Drugs in Dermatology : JDD|December 4, 2024
INDIVIDUAL ARTICLE: USCOM IV Algorithm for the Prevention and Management of Targeted Therapy-Related Cutaneous Adverse EventsJonathan Leventhal, Ana Sofia Acosta Madiedo, Anneke Andriessen, et al.
Journal of Drugs in Dermatology : JDD|September 7, 2021
US Cutaneous Oncodermatology Management (USCOM): A Practical AlgorithmMario E Lacouture, Jennifer Choi, Alice Ho, et al.
Journal of Addiction Medicine|November 7, 2023
Recognition and Treatment of Wounds in Persons Using Xylazine: A Case Report From New Haven, ConnecticutAnne Dowton, Molly Doernberg, Erica Heiman, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|July 9, 2025
New Drugs, New Toxicities: Side Effects of New and Emerging Breast Cancer TherapiesAlexis LeVee, Alana Deutsh, Ethan S Lindgren, et al.
Frontiers in Oncology|November 14, 2025
Use of imiquimod topical therapy for management of malignant melanoma positive marginsKatelyn Lewis, Sara Islam, David P Alper, et al.
Frontiers in Oncology|February 23, 2023
Factors associated with the use of adjuvant radiation therapy in stage III melanomaAmber L O King, Victor Lee, Beverly Yu, et al.
Journal for Immunotherapy of Cancer|June 16, 2019
B cell depletion or absence does not impede anti-tumor activity of PD-1 inhibitorsWilliam Damsky, Lucia Jilaveanu, Noel Turner, et al.
JAAD Case Reports|July 3, 2020
Neoadjuvant anti-programmed cell death 1 therapy for locally advanced basal cell carcinoma in treatment-naive patients: A case seriesKatherine Given Ligtenberg, Jamie Katy Hu, William Damsky, et al.
Pageof 5